Feeds Medizin-HealthCare

HealthCare am MIT

Pilot, engineer, neuroscientist, bridge-builder
by
Creating a versatile vaccine to take on Covid-19 in its many guises
by
New purification method could make protein drugs cheaper
by
MIT-Takeda Program heads into fourth year with crop of 10 new projects
by
Jupneet Singh: Finding purpose through service
by
Improving health outcomes by targeting climate and air pollution simultaneously
by
Custom, 3D-printed heart replicas look and pump just like the real thing
by
Ingestible sensor could help doctors pinpoint GI difficulties
by
Helping companies deploy AI models more responsibly
by
3 Questions: Leo Anthony Celi on ChatGPT and medicine
by
A traveler on bioengineering’s many paths
by
A traveler on bioengineering’s many paths
by
MIT Wellness Wizard Certificate promotes health and well-being
by
A new educational program for scientists working on substance use disorder
by
New collaboration aims to strengthen orthotic and prosthetic care in Sierra Leone
by
Why lung cancer doesn’t respond well to immunotherapy
by
MIT Solve announces 2023 global challenges and Indigenous Communities Fellowship
by
How to make hydrogels more injectable
by
“Spleen-on-a-chip” yields insight into sickle cell disease
by
Unnatural selection
by
Startups led by MIT mechanical engineers offer health care solutions
by
Targeting cancer with a multidrug nanoparticle
by
School of Engineering fourth quarter 2022 awards
by
Portable cap can measure cognition with pulsed laser light
by
Using robotics to supercharge health care
by
MIT researchers develop an AI model that can detect future lung cancer risk
by
MIT researchers develop an AI model that can detect future lung cancer risk
by
Compassion in the details
by
2022-23 Takeda Fellows: Leveraging AI to positively impact human health
by
Enabling advanced studies in Turkey with MIT OpenCourseWare
by
Enzyme “atlas” helps researchers decipher cellular pathways
by
Enzyme “atlas” helps researchers decipher cellular pathways
by
New MIT internships expand research opportunities in Africa
by
Professor Emeritus Richard Wurtman, influential figure in translational research, dies at 86
by
New tool can assist with identifying carbohydrate-binding proteins
by
Valeria Robayo is putting her own twist on the pre-med experience
by
Physician, heal thyself?
by
MIT engineers design a soft, implantable ventilator
by
Honoring Salvador Luria, longtime MIT professor and founding director of the MIT Center for Cancer Research
by
Nanosensors target enzymes to monitor and study cancer
by
A new control system for synthetic genes
by
Angela Koehler takes on the most challenging drug targets
by
Two first-year students named Rise Global Winners for 2022
by
A “door” into the mitochondrial membrane
by
MIT biologist Richard Hynes wins Lasker Award
by
Through mentorship, a deeper understanding of brain cancer metabolism grows
by
Using machine learning to identify undiagnosable cancers
by
How different cancer cells respond to drug-delivering nanoparticles
by
Microparticles could be used to deliver “self-boosting” vaccines
by
How a shape-shifting receptor influences cell growth
by Anne Trafton | MIT News Office on 6. Juli 2022 at 9:00

Insight into the way the EGF receptor sends signals into cells could help researchers design new cancer drugs that target this protein.